CANINE CARE
When your dog has an open wound or infection, TAFA400™ should be the product of choice because it is easy to apply directly onto the affected area to clean the area, treat infection while stabilizing the damages cells to accelerating healing.
FELINE CARE
From scratches to bites to ear and eye infections, cats often receive dangerous injuries. TAFA400™ is the product of choice because it is easy to apply into the affected area and works quickly to treat infection and accelerate healing.
EQUINE CARE
As a triple action wound treatment, TAFA400™ eliminates the need for multiple products while reducing the application time and requirements. Wounds treated with TAFA400™ have demonstrated significant reduction in healing times.
BOVINE CARE
Wounds treated with TAFA400™ have demonstrated significant reduction in healing times. Stabilizing the damaged cells takes less than 60 seconds and lasts for up to 24 hours, reducing infection and inflammation.
The Future of Animal Health
Triamino™ and TAFA400™ are revolutionary formulations developed by Steven R. Schutt and John Everding of the Luminec Group of Companies. Luminec Animal Sciences is the first of the Luminec Group to apply these unique formulations. Luminec Animal Sciences products are composed of water-soluble blends of amino acids that embody all-natural-based healing agents that can be delivered through oral, inhalant, topical, and both arterial and venous administration.
The Triamino™ hydrogen-bonded molecule is based on a proprietary formula that facilitates healing across a broad spectrum of medical ailments and health conditions and has been tested for verification by a series of sophisticated trials using NMR (Nuclear Magnetic Resonance). All test results indicate this new molecule is essentially non-toxic with no side effects, is considered as safe as distilled water, and carries a GRAS status (Generally Recognized As Safe) from the FDA.
Triamino™ in hydrous solution inundates and bonds to the nucleic acids within the unstable nuclei of dysfunctional cells. The resultant biosynthesis causes the unstable nuclei within the cells to align and become stable, returning the cells to their normal functioning as programmed by their original DNA coding which is still implanted within their DNA structure. This mechanism also causes reactivation of the Proliferative phase regulated by the DNA, thus significantly accelerating the healing process.
It is significant to note that the treated body cannot form immunity to the superb anti-inflammatory action of Triamino™ due to the biosynthesis causing cellular stability. The molecule is not a pharmaceutical drug and has multiple applications in the treatment of both animal and human health issues. Luminec Life Sciences, a division of Luminec Pharmaceuticals, presently has more than 1,200 written endorsements from patients and doctors, plus over 700 testimonials from veterinarians and pet owners, each one attesting to the amazing effectiveness of our molecules.
TAFA400™ combines the Triamino™ molecule with Carbohydrate Derived Fulvic Acid (CHD-FA) to create all-natural, broad-spectrum, anti-fungal, anti-microbial, anti-bacterial and anti-viral products. This formulation combining Triamino™ and CHD-FA eliminates the problems encountered with mineral derived Fulvic Acid (FA) and also carries a GRAS (Generally Recognized As Safe) status from the FDA status.
TAFA400™ benefits from this blending of Carbohydrate Derived Fulvic Acid in a chemically pure pharmaceutical grade with the Triamino™ molecule, producing the most effective non-toxic, all-natural, broad-spectrum, anti-fungal, anti-bacterial, anti-microbial, and anti-viral agent known to man. The treatments derived from these molecules have demonstrated properties that rapidly clean and heal broad-spectrum topical wounds, including all degrees of burns, topical lesions and ulcers, fungi, and spores, providing instant relief from pain, itching, bleeding, burning and inflammation for both animals and humans.
MOREThe Latest Luminec News
Co-Founder Steven Schutt Interview
Scientist and co-founder Steven R. Schutt discusses the discovery and range of applications of his revolutionary cellular regeneration formulas Triamino™ and TAFA400™.
Success Stories
The Science
Our Parent Company

Contact Us
Luminec Animal Sciences Corp.
A division of Luminec Holdings, Inc.
John Everding, Founder
Gary Sater, COO
Eric H. Kim, CFO
Manufacturing Partners
U.S. Manufacturing
Luminec Pharmaceuticals
2142 Industrial Court
Suite F
Vista, CA 92081
Mexico/Central & South America Manufacturing & Distribution
Laboratorio Mederilab
Invett
China Distribution
Frank Zhang, Exclusive Asia
Philippines Distribution
Catala Corporation
India Distribution
Pending










